Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk and Alzheimer’s disease.
May 1, 2019 13:05 UTC
--(BUSINESS WIRE)-- Eyenuk Inc. is a global artificial intelligence (AI) medical technology company and the leader in real-world AI Eye Screening™ for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk and Alzheimer’s disease.
| Company: | Eyenuk Inc. | |||
| Headquarters Address: | 5850 Canoga Ave. | |||
| Suite 250 | ||||
| Woodland Hills, CA 91367 | ||||
| Main Telephone: | (818) 835-3585 | |||
| Website: | ||||
| Type of Organization: | Private | |||
| Industry: | Optical | |||
| Key Executives: | CEO: Kaushal Solanki | |||
| Public Relations | ||||
| Contact: | Kimberly Capwell | |||
| Phone: | 949.999.3303 | |||
| Email: |
View source version on businesswire.com: https://www.businesswire.com/news/home/20190501005177/en/
Source: Eyenuk Inc.
View this news release online at:
http://www.businesswire.com/news/home/20190501005177/en
